CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES >
Progress of echinococcosis control in China, 2022
Received date: 2023-09-22
Revised date: 2023-11-03
Online published: 2024-03-12
Supported by
National Key Research and Development Program of China(2021YFC2300800);National Key Research and Development Program of China(2021YFC2300804)
To understand the work progress in nationwide control of echinococcosis, we summarize the experience and find the existing problems through descriptive analysis on the national control data in 2022. As of the end of 2022, there were 370 echinococcosis endemic counties (city, district, banner) covering 29 926 villages in China, having a total of 25 227 echinococcosis cases with an average prevalence of 58.35 per 100 000 (25 227/43 232 609), among them, 15 554 cases were of cystic echinococcosis, 8 169 cases alveolar echinococcosis, 255 mixed infection, and 1 249 cases pending; 1 270 cases were newly found, including 991 cases of cystic echinococcosis, 89 alveolar echinococcosis, 5 mixed infection, and 185 pending; revealing 102 cases were at age < 12, and 1 168 case were of age ≥ 12. In 2022, population screening by abdominal ultrasound scanning was performed in all endemic provinces (autonomous regions) for 3 576 121 person/times. Of them, 751 440 person/examinations were performed for the residents younger than 12, and 2 824 681 person/times were performed for residents older than 12. The serological examination was carried out for the suspected individuals for 17 404 person/times. According to data from 370 surveillance sites in 2022, the prevalence in residents younger than 12 was 0.02% (60/287 437) by ultrasound screening, with 40.00% (24/60) newly diagnosed cases. The prevalence in the residents older than 12 was 0.29% (772/270 407) in type Ⅰ and type Ⅱ endemic counties (city, district, banner). The newly diagnosed cases accounted for 8.29% (64/772) of the detected patients. In 2022, 18 354 patients received drug treatment, of which 16 625 patients received liver and kidney function tests or management against adverse reactions. A total of 1 418 patients received surgical treatment, including 69.82% (990/1 418) for cystic echinococcosis, and 26.52% (376/1 418) for alveolar echinococcosis. In 2022, the follow-up results showed that 999 cases were cured, 20 599 cases responded to the treatment, 2 546 cases failed in the treatment, 374 cases died (the causes of the deaths were not echinococcosis), 239 cases were excluded, 372 cases were lost in follow-up, 884 cases had not completed the follow-up, and 170 cases migrated to other places. In 2022, there were 2 478 608 dogs in the endemic townships (towns) nationwide, of which 2 250 694 were registered for management. Deworming work was conducted for dogs in 34 646 villages, with 24 289 457 deworming times. Wild canines were demormed by delivering 119 473 drug doses. A total of 394 851 fecal samples from domestic dogs were collected and detecteded, of which 1 756 were found positive for Echinococcus coproantigen, with a positive rate of 0.44% (1 756/394 851). Of the wild canines, 62 884 field fecal samples were collected and detected, among which 1 201 were found positive for Echinococcus coproantigen, with a positive rate of 1.91% (1 201/62 884). A total of 117 303 slaughtered livestock were randomly examined, among which 1 038 were diseased, with a prevalence of 0.88%. A total of 43 705 field rodents were examined, among which 403 were diseased, with a prevalence of 0.92%. Although the endemic of echinococcosis in China has been essentially controlled, there remain many difficulties and challenges in control work. It is imperative to continuously strengthen the prevention and control measures for echinococcosis, raise the disease prevention awareness, explore optimizing the control strategy, exert the role of regional joint prevention and control mechanisms and fully implement comprehensive measures to further control the prevalence of echinococcosis.
Key words: Echinococcosis; Cystic echinococcosis; Alveolar echinococcosis; Epidemiology; China
KUI Yan , XUE Chuizhao , WANG Xu , LIU Baixue , WANG Ying , WANG Liying , YANG Shijie , HAN Shuai , XU Xuenian . Progress of echinococcosis control in China, 2022[J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2024 , 42(1) : 8 -16 . DOI: 10.12140/j.issn.1000-7423.2024.01.002
| [1] | Wen H, Vuitton L, Tuxun T, et al. Echinococcosis: advances in the 21st century[J]. Clin Microbiol Rev, 2019, 32(2): e00075 |
| [2] | Wang Q, Yang L, Wang YF, et al. Disease burden of echinococcosis in Tibetan communities: a significant public health issue in an underdeveloped region of Western China[J]. Acta Trop, 2020, 203: 105283. |
| [3] | Torgerson PR, Budke CM. Echinococcosis: an international public health challenge[J]. Res Vet Sci, 2003, 74(3): 191-202. |
| [4] | National Health and Family Planning Commission, United Front Work Department of the CPC Central Committee, National Development and Reform Commission, et al. Notice on printing and distributing the national plan for the prevention and control of key parasitic diseases such as echinococcosis (2016—2020)[J]. Gaz Natl Heath Fam Plan Comm People’s Repub Chin, 2016(11): 9-14. (in Chinese) |
| 国家卫生计生委, 中央统战部, 国家发展改革委, 等. 关于印发全国包虫病等重点寄生虫病防治规划(2016—2020年)的通知[J]. 中华人民共和国国家卫生和计划生育委员会公报, 2016(11): 9-14.) | |
| [5] | Yan J, Hu T, Lei ZL. The endemic situation and challenges of major parasitic diseases in China[J]. Chin J Parasitol Parasit Dis, 2015, 33(6): 412-417. (in Chinese) |
| (严俊, 胡桃, 雷正龙. 全国重点寄生虫病的防控形势与挑战[J]. 中国寄生虫学与寄生虫病杂志, 2015, 33(6): 412-417.) | |
| [6] | Zheng CJ, Yang L, Zhang GJ, et al. Interpretation of technical scheme for echinococcosis control (edition 2019)[J]. J Trop Dis Parasitol, 2020, 18(4): 193-196, 201. (in Chinese) |
| 郑灿军, 杨柳, 张光葭, 等. 《包虫病防治技术方案(2019年版)》解读[J]. 热带病与寄生虫学, 2020, 18(4):193- 196, 201.) | |
| [7] | Han S, Kui Y, Xue CZ, et al. The endemic status of echinococcosis in China from 2004 to 2020[J]. Chin J Parasitol Parasit Dis, 2022, 40(4): 475-480. (in Chinese) |
| (韩帅, 蒉嫣, 薛垂召, 等. 2004—2020年全国棘球蚴病疫情分析[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(4): 475-480.) | |
| [8] | Fu MH, Han S, Xue CZ, et al. Contribution to the echinococcosis control programme in China by NIPD-CTDR[J]. Adv Parasitol, 2020, 110: 107-144. |
| [9] | Wu WP, Wang H, Wang Q, et al. A nationwide sampling survey on echinococcosis in China during 2012—2016[J]. Chin J Parasitol Parasit Dis, 2018, 36(1): 1-14. (in Chinese) |
| (伍卫平, 王虎, 王谦, 等. 2012—2016年中国棘球蚴病抽样调查分析[J]. 中国寄生虫学与寄生虫病杂志, 2018, 36(1): 1-14.) | |
| [10] | Kui Y, Xue CZ, Wang X, et al. Progress of echinococcosis control in China, 2021[J]. Chin J Parasitol Parasit Dis, 2023, 41(2): 142-148. (in Chinese) |
| (蒉嫣, 薛垂召, 王旭, 等. 2021年全国棘球蚴病防治进展[J]. 中国寄生虫学与寄生虫病杂志, 2023, 41(2): 142-148.) | |
| [11] | Kern P, Menezes da Silva A, Akhan O, et al. The echinococcoses: diagnosis, clinical management and burden of disease[J]. Adv Parasitol, 2017, 96: 259-369. |
| [12] | He YW, Cui QQ, Hu ZY. Modeling and analysis of the transmission dynamics of cystic echinococcosis: effects of increasing the number of sheep[J]. Math Biosci Eng, 2023, 20(8): 14596-14615. |
| [13] | Kachani M, Heath D. Dog population management for the control of human echinococcosis[J]. Acta Trop, 2014, 139: 99-108. |
| [14] | Xiao J, Yu HM, Yang Y, et al. Analysis of the equity of health human resource allocation for echinococcosis control based on Gini index[J]. Chin J Schisto Control, 2022, 34(3): 292-299. (in Chinese) |
| (肖洁, 余红梅, 杨义, 等. 基于基尼系数的棘球蚴病防治卫生人力资源配置公平性分析[J]. 中国血吸虫病防治杂志, 2022, 34(3): 292-299.) | |
| [15] | Zhou MH, Shao M, He SZ, et al. Analysis of human resource development status of Sichuan Center for Disease Control and Prevention[J]. Med Soc, 2021, 34(1): 29-33. (in Chinese) |
| (周明华, 邵茂, 谭红, 等. 四川省疾病预防控制中心人力资源发展状况分析[J]. 医学与社会, 2021, 34(1): 29-33.) | |
| [16] | Hu H, Jiang SY, Liang XX. Analysis on status and equity of human resource allocation of disease prevention and control institutions in Inner Mongolia from 2016—2018[J]. Med Soc, 2021, 34(9): 22-26, 43. (in Chinese) |
| (胡晗, 江世英, 梁鑫鑫. 2016—2018年内蒙古疾控机构人力资源配置状况及公平性分析[J]. 医学与社会, 2021, 34(9):22-26, 43.) | |
| [17] | Shen XX, Zhou Q, Luo WW, et al. Analysis on the present situation of human resources of disease control institutions in Aksu region in 2020[J]. Bull Dis Control Prev China, 2021, 36(4): 79-81. (in Chinese) |
| (沈新秀, 周权, 罗文伟, 等. 2020年阿克苏地区疾控机构人力资源现状分析[J]. 疾病预防控制通报, 2021, 36(4): 79-81.) | |
| [18] | Zou JT, Guo Y, Chen Y, et al. Current situation of human resources in disease control and prevention institutions[J]. Shanghai J Prev Med, 2021, 33(1): 6-12. (in Chinese) |
| (邹佳彤, 郭颖, 陈勇, 等. 疾病预防控制机构人力资源现况及存在问题分析[J]. 上海预防医学, 2021, 33(1): 6-12.) | |
| [19] | Lin XD, Xu BX, Wang D, et al. Distribution characteristics and prediction analysis of human resources in professional public health institutions in China[J]. Chin Heath Serv Manag, 2021, 38(12): 904-908, 949. (in Chinese) |
| (林小丹, 徐碧霞, 王冬, 等. 我国专业公共卫生机构人力资源分布特征及预测分析[J]. 中国卫生事业管理, 2021, 38(12): 904-908, 949.) | |
| [20] | Zhou XN. Advancing the prevention and control of zoonoses supported by One Health approach[J]. Chin J Parasitol Parasit Dis, 2022, 40(1): 12-19. (in Chinese) |
| (周晓农. 以全健康理念推进人兽共患病预防与控制[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(1): 12-19.) |
/
| 〈 |
|
〉 |